A company description is not available for this instrument.
Research context
Stemcell United Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Stemcell United Limited is currently in a long term downtrend where the price is trading 12.7% below its 200 day moving average.
From a valuation standpoint, the stock is 92.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 19.3.
Stemcell United Limited's total revenue rose by 411.6% to $4M since the same quarter in the previous year.
Its net income has dropped by 64.9% to $-1M since the same quarter in the previous year.
Finally, its free cash flow fell by 68.9% to $-535K since the same quarter in the previous year.
Based on the above factors, Stemcell United Limited gets an overall score of 2/5.